Bass, Berry & Sims attorney Clint Hermes provided insight for an article in WIRED examining a Chinese inventor’s intention to bring his cancer treatment to the United States. Xuewu Liu, a Chinese inventor, has been treating cancer patients with an AI-driven treatment that involves injecting cancerous tumors with a highly concentrated dose of chlorine dioxide – a bleach solution. Liu has no formal medical training and currently prepares the chlorine dioxide in his home. To date, there have been no widespread clinical human trials to confirm the efficacy of the treatment.
Liu believes this therapy is legal under Article 37 of the Declaration of Helsinki and the US Right to Try Laws and may not need approval from the Food and Drug Administration (FDA). WIRED reached out to Clint for insight due to his “extensive expertise in biomedical research,” who responded to Liu’s claims saying, “It sounds like Mr. Liu may not understand how the Right to Try Act or the Declaration of Helsinki work or how they fit within the broader context in which the FDA regulates investigational drugs. If he is under the impression that the ‘breast cancer trial’ referenced on his website is sufficient on its own to allow him to market or study his therapy in the US under right to try and/or the Declaration of Helsinki, he is mistaken.”
The full article, “An Inventor Is Injecting Bleach Into Cancerous Tumors—and Wants to Bring the Treatment to the US,” was published by WIRED on July 24 and is available online.